MedPath

Schema therapy for Anorexia Nervosa

Recruiting
Conditions
eating disorder
feeding disorder
10014067
Registration Number
NL-OMON53672
Lead Sponsor
Parnassia Groep.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

- A DSM-5 diagnosis anorexia nervosa
- Age between 16-65 years
- BMI >= 15 and somatically stabile as is defined in the department*s crisis
protocol and evaluated by a physician specialised in eating disorders.

Exclusion Criteria

- Patients in an acute state of mental crisis who need immediate
hospitalization or treatment for high suicide risk
- Patients with intellectual disability
- Patients who cannot complete the questionnaires because of insufficient
language skills, practical or cognitive limitations
- Not willing (or being able) to sign the informed consent form of this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>This study investigates the effects of a thirty week schema therapy in reducing<br /><br>eating disorder symptoms of patients with anorexia nervosa.<br /><br>Hypothesis:<br /><br>Based on previous research (McIntosh et al., 2016; Pauwels, Dierckx,<br /><br>Schoevaerts, & Claes, 2016; Pugh, 2015; Simpson et al., 2010; Waller, Dickson,<br /><br>& Ohanian, 2002) it is expected that schema therapy will improve eating<br /><br>disorder symptoms for patients with anorexia nervosa. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>This study seeks to examine the changing nature of schema*s and modes in<br /><br>patients with anorexia nervosa during schema therapy.<br /><br>Hypothesis: It is expected to demonstrate a reduction in schema*s and modes for<br /><br>patients with anorexia nervosa during schema therapy. </p><br>
© Copyright 2025. All Rights Reserved by MedPath